71250

RadiologyCMS status: A

Computed tomography of the thorax (chest) without contrast material. CMS 2026 global wRVU 1.08, total RVU approximately 3.57, Medicare global allowable approximately $119. Used for pulmonary nodule characterization, low-dose lung screening (when paired with appropriate G-codes), and chest pathology not requiring vascular contrast detail.

Work RVU
1.08
Practice RVU
2.41
Malpractice RVU
0.08
Total RVU
3.57
2026 Medicare payment
$119.24
National GPCI = 1.000 · Conversion factor $33.4009 · Non-facility
Model this code

Drop 71250 into a scenario to see how unit volume rolls up to annual wRVUs, gross collections, and bonus.

Open in calculator →

When to use it

Use 71250 when chest CT without contrast is the indicated study: pulmonary nodule follow-up per Fleischner Society guidelines, interstitial lung disease evaluation, COPD/emphysema characterization, pre-operative thoracic surgery planning, suspected pulmonary fibrosis. 71260 (with contrast) is used for hilar mass, mediastinal lymphadenopathy, post-treatment oncology surveillance. 71270 (without and with) is reserved for complex cases requiring both characterizations. 71275 (CTA chest) is the PE-protocol study with timed contrast bolus and is a different code. For Medicare low-dose CT lung cancer screening, use G0297 (the screening-specific HCPCS code) instead of 71250.

Documentation checklist

Common pitfalls

Common modifiers
26TC
Common ICD-10 pairings
R91.1J84.10J44.9C34.90R09.81

Payer notes

Medicare covers 71250 with appropriate indication. Lung cancer screening is a separate benefit under G0297 with strict eligibility (age 50 to 77, 20 pack-year history, current smoker or quit within 15 years, asymptomatic). Commercial payers vary on prior auth requirements; most reserve auth for outpatient chest CT without urgent indication. Some Medicare Advantage plans deny 71250 if an outpatient indication doesn't reach a documented threshold of suspicion.

Pairs well with

Educational reference, not billing or legal advice. Verify against your payer contracts and your compliance team before submission.